Early-stage cervical cancer: is surgery better than radiotherapy?

References

• World Health Organisation. Comprehensive cervical cancer control. In: A Guide to Essential Practice. WHO Geneva, Switzerland (2006).
   Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55(2), 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Park SY, Bae DS, Nam JH et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer110(12), 2716–2725 (2007).
   PubMed Web of Science ®Google Scholar
• Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet350(9077), 535–540 (1997).
   PubMed Web of Science ®Google Scholar
• Petsuksiri J, Chansilpa Y, Therasakvichya S et al. Treatment options in bulky stage IB cervical carcinoma. Int. J. Gynecol. Cancer18(6), 1153–1162 (2008).
   PubMedGoogle Scholar
• Wertheim E. The extended abdominal operation for carcinoma uteri (based on 500 operative cases). Am. J. Obstet. Dis. Women Child66, 169–232 (1912).
   Google Scholar
• Bartos P, Struppl D, Trhlik M et al. Da Vinci robotic surgery in gynaecological oncology: a critical interim appraisal. Ceska. Gynekol.72(5), 354–359 (2007).
   PubMedGoogle Scholar
• Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet. Gynecol.44(2), 265–272 (1974).
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Cragun JM, Calingaert B et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol. Oncol.99(3), 689–695 (2005).
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim SH, Choi HJ, Park BK, Lee HJ. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study. J. Comput. Assist. Tomogr.28(5), 620–627 (2004).
   PubMed Web of Science ®Google Scholar
• Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C. Pretreatment staging of cervical cancer: is imaging better than palpation? Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients. Ann. Surg. Oncol.15(10), 2856–2861 (2008).
   PubMedGoogle Scholar
• Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet. Gynecol.86(1), 43–50 (1995).
   PubMed Web of Science ®Google Scholar
• Wagenaar HC, Trimbos JB, Postema S et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol. Oncol.82(3), 474–482 (2001).
   PubMedGoogle Scholar
• Hricak H, Gatsonis C, Coakley FV et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation – ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology245(2), 491–498 (2007).
   PubMed Web of Science ®Google Scholar
• Jackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. Int. J. Gynecol. Cancer16(1), 354–363 (2006).
   PubMedGoogle Scholar
• Querleu D, Leblanc E, Cartron G, Narducci F, Ferron G, Martel P. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am. J. Obstet. Gynecol.195(5), 1287–1292 (2006).
   PubMed Web of Science ®Google Scholar
• Matsuura Y, Kawagoe T, Toki N, Tanaka M, Kashimura M. Long-standing complications after treatment for cancer of the uterine cervix – clinical significance of medical examination at 5 years after treatment. Int. J. Gynecol. Cancer16(1), 294–297 (2006).
   PubMedGoogle Scholar
• Wu K, Zhang WH, Zhang R, Li H, Bai P, Li XG. [Analysis of postoperative complications of radical hysterectomy for 219 cervical cancer patients]. Zhonghua Zhong Liu Za Zhi28(4), 316–319 (2006).
   PubMedGoogle Scholar
• Zullo MA, Manci N, Angioli R, Muzii L, Panici PB. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit. Rev. Oncol. Hematol.48(3), 287–293 (2003).
   PubMed Web of Science ®Google Scholar
• Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph nodes in early stage cervical cancer. Gynecol. Oncol.105(2), 285–290 (2007).
   PubMed Web of Science ®Google Scholar
• Li G, Yan X, Shang H, Wang G, Chen L, Han Y. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib–IIa cervical cancer. Gynecol. Oncol.105(1), 176–180 (2007).
   PubMed Web of Science ®Google Scholar
• Lowe MP, Chamberlain DH, Kamelle SA, Johnson PR, Tillmanns TD. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer. Gynecol. Oncol.113(2), 191–194 (2009).
   PubMedGoogle Scholar
• Nam JH, Kim JH, Kim DY et al. Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer. Gynecol. Oncol.92(1), 277–283 (2004).
   PubMedGoogle Scholar
• Di Stefano AB, Acquaviva G, Garozzo G et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol. Oncol.99(3), 671–679 (2005).
   PubMedGoogle Scholar
• Altgassen C, Hertel H, Brandstadt A, Kohler C, Durst M, Schneider A. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO study group. J. Clin. Oncol.26(18), 2943–2951 (2008).
   PubMed Web of Science ®Google Scholar
• Leblanc E, Narducci F, Frumovitz M et al. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol. Oncol.105(2), 304–311 (2007).
   PubMedGoogle Scholar
• Marnitz S, Kohler C, Roth C, Fuller J, Hinkelbein W, Schneider A. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol. Oncol.99(3), 536–544 (2005).
   PubMed Web of Science ®Google Scholar
• Vergote I, Tsolakidis D, Mortier D et al. Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2–IIIB. J. Clin. Oncol.26(34), 5654–5655 (2008).
   PubMedGoogle Scholar
• Boughanim M, Leboulleux S, Rey A et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F] fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J. Clin. Oncol.26(15), 2558–2561 (2008).
   PubMedGoogle Scholar
• Kim PY, Monk BJ, Chabra S et al. Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging. Gynecol. Oncol.69(3), 243–247 (1998).
   PubMedGoogle Scholar
• Yabuki Y, Asamoto A, Hoshiba T, Nishimoto H, Kitamura S. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am. J. Obstet. Gynecol.164(1 Pt 1), 7–14 (1991).
   PubMed Web of Science ®Google Scholar
• Raspagliesi F, Ditto A, Hanozet F et al. Nerve-sparing radical hysterectomy in cervical cancer: evolution of concepts. Gynecol. Oncol.107(1 Suppl. 1), S119–S121 (2007).
   PubMed Web of Science ®Google Scholar
• Höckel M, Konerding MA, Peter Heuel C. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am. J. Obstet. Gynecol.178(5), 971–976 (1998).
   PubMed Web of Science ®Google Scholar
• Rob L, Pluta M, Strnad P et al. A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer. Gynecol. Oncol.111(2 Suppl.), S116–S120 (2008).
   PubMed Web of Science ®Google Scholar
• Hoffman MS. Extent of radical hysterectomy: evolving emphasis. Gynecol. Oncol.94(1), 1–9 (2004).
   PubMedGoogle Scholar
• Stegeman M, Louwen M, van der Velden J et al. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol. Oncol.105(2), 475–480 (2007).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Schover LR, Partridge AH et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18), 2917–2931 (2006).
   PubMed Web of Science ®Google Scholar
• Milliken DA, Shepherd JH. Fertility preserving surgery for carcinoma of the cervix. Curr. Opin. Oncol.20(5), 575–580 (2008).
   PubMedGoogle Scholar
• Diaz JP, Sonoda Y, Leitao MM et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol. Oncol.111(2), 255–260 (2008).
   PubMed Web of Science ®Google Scholar
• Beiner ME, Hauspy J, Rosen B et al. Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case–control study. Gynecol. Oncol.110(2), 168–171 (2008).
   PubMedGoogle Scholar
• Leitao MM Jr, Chi DS. Fertility-sparing options for patients with gynecologic malignancies. Oncologist10(8), 613–622 (2005).
   PubMedGoogle Scholar
• Chuang LT, Lerner DL, Liu CS, Nezhat FR. Fertility-sparing robotic-assisted radical trachelectomy and bilateral pelvic lymphadenectomy in early-stage cervical cancer. J. Minim. Invasive. Gynecol.15(6), 767–770 (2008).
   PubMed Web of Science ®Google Scholar
• Farthing A. Conserving fertility in the management of gynaecological cancers. Br. J. Obstet. Gynaecol.113(2), 129–134 (2006).
   Google Scholar
• Chen Y, Xu H, Zhang Q, Li Y, Wang D, Liang Z. A fertility-preserving option in early cervical carcinoma: laparoscopy-assisted vaginal radical trachelectomy and pelvic lymphadenectomy. Eur. J. Obstet. Gynecol. Reprod. Biol.136(1), 90–93 (2008).
   PubMedGoogle Scholar
• Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. Br. J. Obstet. Gynaecol.108(8), 882–885 (2001).
   Google Scholar
• Ungar L, Palfalvi L, Hogg R et al. Abdominal radical trachelectomy: a fertility-preserving option for women with early cervical cancer. Br. J. Obstet. Gynaecol.112(3), 366–369 (2005).
   Google Scholar
• Plante M, Renaud MC, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol. Oncol.98(1), 3–10 (2005).
   PubMed Web of Science ®Google Scholar
• Bernardini M, Barrett J, Seaward G, Covens A. Pregnancy outcomes in patients after radical trachelectomy. Am. J. Obstet. Gynecol.189(5), 1378–1382 (2003).
   PubMed Web of Science ®Google Scholar
• Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int. J. Radiat. Oncol. Biol. Phys.28(2), 335–341 (1994).
   PubMed Web of Science ®Google Scholar
• Hareyama M, Sakata K, Oouchi A et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer94(1), 117–124 (2002).
   PubMed Web of Science ®Google Scholar
• Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys.59(5), 1424–1431 (2004).
   PubMedGoogle Scholar
• Kleinerman RA, Boice JD Jr, Storm HH et al. Second primary cancer after treatment for cervical cancer. An International Cancer Registries study. Cancer76(3), 442–452 (1995).
   PubMedGoogle Scholar
• Ploch E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol. Oncol.26(2), 169–177 (1987).
   PubMed Web of Science ®Google Scholar
• Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical–pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecology Oncology Group study. Gynecol. Oncol.38(3), 352–357 (1990).
   PubMed Web of Science ®Google Scholar
• Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecology Oncology Group study. Gynecol. Oncol.73(2), 177–183 (1999).
   PubMed Web of Science ®Google Scholar
• Rotman M, Sedlis A, Piedmonte MR et al. A Phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys.65(1), 169–176 (2006).
   PubMed Web of Science ®Google Scholar
• Peters WA 3rd, Liu PY, Barrett RJ 2nd et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol.18(8), 1606–1613 (2000).
   PubMed Web of Science ®Google Scholar
• Kjorstad KE, Martimbeau PW, Iversen T. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital: results and complications. III. Urinary and gastrointestinal complications. Gynecol. Oncol.15(1), 42–47 (1983).
   PubMedGoogle Scholar
• Greimel ER, Winter R, Kapp KS, Haas J. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology18(5), 476–482 (2009).
   PubMed Web of Science ®Google Scholar
• Tierney JF, Vale C, Symonds P. Concomitant and neoadjuvant chemotherapy for cervical cancer. Clin. Oncol. (R. Coll. Radiol.)20(6), 401–416 (2008).
   PubMedGoogle Scholar
• Eddy GL, Bundy BN, Creasman WT et al. Treatment of (‘bulky’) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a Phase III trial of the Gynecologic Oncology Group. Gynecol. Oncol.106(2), 362–369 (2007).
   PubMedGoogle Scholar
• Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib–IIIb), a long-term randomized trial. Eur. J. Gynaecol. Oncol.24(1), 51–59 (2003).
   PubMed Web of Science ®Google Scholar
• Sardi JE, Giaroli A, Sananes C et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol. Oncol.67(1), 61–69 (1997).
   PubMed Web of Science ®Google Scholar
• Cai HB, Chen HZ, Yin HH. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J. Obstet. Gynaecol. Res.32(3), 315–323 (2006).
   PubMedGoogle Scholar
• Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J. Clin. Oncol.20(1), 179–188 (2002).
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Parmar MK. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix? Eur. J. Cancer35(3), 406–409 (1999).
   PubMedGoogle Scholar
• Hsu WC, Chung NN, Chen YC et al. Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer. Eur. J. Cancer35(3), 406–409 (1999).
   PubMedGoogle Scholar
• Quality of life and sexual functioning in cervical cancer survivors. J. Clin. Oncol.23(30), 7428–7436 (2005).
   PubMed Web of Science ®Google Scholar
• Sundar S, Horne A, Kehoe S. Cervical cancer. Clin. Evid. (13), 2285–2292 (2005).
   PubMedGoogle Scholar
• Waggoner SE. Cervical cancer. Lancet361(9376), 2217–2225 (2003).
   PubMed Web of Science ®Google Scholar
• Schover LR, Fife M, Gershenson DM. Sexual dysfunction and treatment for early stage cervical cancer. Cancer63(1), 204–212 (1989).
   PubMed Web of Science ®Google Scholar
• Yessaian A, Magistris A, Burger RA, Monk BJ. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecol. Oncol.94(1), 61–66 (2004).
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecology Oncology Group. Gynecol. Oncol.89(3), 343–353 (2003).
   PubMedGoogle Scholar
• Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al. A Phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann. Oncol.14(8), 1278–1284 (2003).
   PubMed Web of Science ®Google Scholar
• Minagawa Y, Kigawa J, Irie T, Okada M, Kanamori Y, Terakawa N. Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer. Ann. Surg. Oncol.5(6), 539–543 (1998).
   PubMedGoogle Scholar
• Takeshima N, Umayahara K, Fujiwara K, Hirai Y, Takizawa K, Hasumi K. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB–IIA cervical cancer. Gynecol. Oncol.103(2), 618–622 (2006).
   PubMedGoogle Scholar